Table 1.
Monogenic cSVDs
| Disease | Gene | Gene function | Vascular pathology | Clinical symptoms | Refs. |
|---|---|---|---|---|---|
| CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) (OMIM: 125310) | NOTCH3 | Encodes NOTCH3 transmembrane receptor that is involved in arterial differentiation and vascular smooth muscle cell remodeling. | NOTCH3 ectodomain aggregation and accumulation in the extracellular space of small vessels, intimal thickening, degeneration of SMCs. | Subcortical lacunar infarcts, vascular dementia, migraine with aura, psychiatric disturbances. | 48, 78–80 |
| CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) (OMIM: 600142) | HTRA1 | Encodes High temperature requirement protein A1, a serine protease. Loss of HTRA1 function is associated with dysregulation of the TGF-β pathway. Emerging evidence suggest that heterozygous mutations also can cause early onset cSVD. |
TGF-β signaling has a key role in vessel development and maintenance, acting in both endothelial and SMCs. Pathological studies showed extensive loss of SMC and deposition of fibro-hyaline material in the media. | Subcortical lacunar infarcts, vascular dementia, alopecia, spondylosis. | 81–83 |
| COL4-related angiopathies (OMIM: 607595; 614519) | COL4A1, COL4A2 | Encodes alpha1 and alpha2 collagen chains, which are important components of the extracellular matrix. | Basement membrane abnormalities. | ICH, infantile hemiparesis, Axenfeld-Rieger anomaly, nephropathy, porencephalopathy. | 27, 84 |
| RVCL-S (retinal vasculopathy with cerebral leukodystrophy and systemic manifestations) (OMIM: 192315) | TREX1 | Encodes DNase III, which plays a role in DNA repair. | Basement membrane defects in capillaries. | Retinal vasculopathy, subcortical lacunar infarcts, white matter hyperintensities, pseudotumors, migraine, cognitive impairment, psychiatric disturbances. | 85, 86 |
| FOXC1/PITX2-related SVD | FOXC1, PITX2 | FOXC1 encodes forkhead box transcription factor C1, which is involved in blood vessel development. PITX2 encodes paired-like homeodomain transcription factor 2, which is involved in left-right asymmetry of internal organs. FOXC1 interacts with PITX2. | Changed endothelial and pericyte proliferation and impaired blood-brain barrier integrity in animal models. | Stroke, WMH, Axenfield-Rieger anomaly. | 87–89 |
| Deficiency of ADA2 (DADA2) | CECR1 | Encodes adenosine deaminase 2 (ADA2). ADA2 plays a role in downregulation of extracellular adenosine, and cellular proliferation and differentiation. | Neutrophils and macrophages in interstitium with perivascular T-lymphocytes. | Small subcortical ischemic and hemorrhagic strokes, intermittent fevers, raised acute phase proteins, livedoid rash, hepatosplenomegaly | 90, 91 |
| CARASAL (cathepsin A related arteriopathy with strokes and leukoencephalopathy) | CTSA | Encodes cathepsin A, which is involved in the lysosomal transport, activation, and stabilization of β-galactosidase and neuraminidase-1. Cathepsin A inactivates selected neuropeptides and regulates a lysosomal pathway of protein degradation. | Fibrous thickening of the small vessels. | Subcortical ischemic and hemorrhagic strokes, cognitive impairment, swallowing difficulties, dry eyes and mouth, muscle cramps, treatment-resistant hypertension | 92, 93 |